Illumina Launch 100 K Genome Effort to Advance Cancer and Rare Disease Research
AI
Designing Digital Healthcare Systems for the Future of Patient-Centered Care
Digital Health
START and Advarra Unite to Streamline Early-Phase Oncology Trials with Speed
START Hope Hub Connect Patients and Physicians with Faster, Smarter Trial Access
The Internet of Medical Things needs a new security model to fulfil its potential
The Role of AI in the Future of Drug Discovery: Redefining Accuracy...
New AI Model VersAI™ Elevates AI Accuracy in Drug Discovery with Sparse Data
Machine Learning Could Detect Disease from Proteins 15 Years Before It Strikes
Oregon & Lantern Pharma's Strategic AI Collaboration to Enhance Cancer Drug
A New AI-Driven Drug Discovery Company, Xaira Therapeutics, Launches with $1 Billion
Revolutionizing Drug Discovery with AI-Powered PleioGraph: 100 Times Faster
Digital Therapeutics: The Promise of Virtual Reality Masks in Treating PTSD Symptoms
AbbVie Joins Forces with ConcertAI and Caris in Landmark Oncology Partnership
The First AI-Assisted Video Capsule Endoscopy: FDA Approves AnX Robotica's ProScan
AI Against Superbugs: MIT's Discovery of a Revolutionary New Class of Antibiotics
Thermo Fisher Launches CorEvidence for Advanced Clinical Research
AI-Supported Skin Scanning Revolutionizes Diabetes Diagnosis and Monitoring
A New Frontier in Medical Imaging: FDA Approves AI-Driven X-Ray for Chest Screening
Merck and Acceleration Collaborate to Revolutionize Scientific Discovery with AI
Amgen and Amazon Collaborate to Transform Drug Manufacturing with Power of AI
New Acoustic AI Model Achieves 83% Accuracy in Detecting Depression
New AI Model Detects Antibiotic Resistance with Over 80% Accuracy
New AI Model Predicts Ovarian Cancer Therapy Success with 80% Accuracy
Revolutionary AI Approach Uses Satellite Imaging for Personalized Cancer Treatment
AI Collaboration: PostEra and Amgen Team Up for Next-Gen Drug Discovery
University of Miami Integrates AI into Its Health System to Maximize Patient Care
Revolutionary Wireless Bioelectronic Implant Detects Early Signs of Organ Rejection
PreciseDx's New AI-Powered Digital Test Predicts Early Breast Cancer Recurrence
Klinrisk: A Breakthrough AI Model Predicting Kidney Disease Progression for Millions
Scientists Have Developed Next-Generation Drug with AI Collaboration
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
